Human papillomavirus (HPV) seroprevalence and determinants of seropositivity were
assessed in a 10 049-woman population-based cohort in Guanacaste, Costa Rica …

Determinants of human papillomavirus (HPV)-16 serological conversion and persistence
were assessed in a population-based cohort of 10 049 women in Guanacaste, Costa Rica …

Infection with human papillomavirus (HPV) type 16 accounts for about half of cervical
cancers worldwide. This study investigated the seroepidemiology of HPV-16 infection in the …

Human papillomavirus (HPV) DNA has been detected in the great majority of cancers of the
uterine cervix and anus, whereas the association of HPV DNA with cancer at other …

A human papillomavirus type 16 (HPV-16) virus-like particle (VLP)-based enzyme-linked
immunosorbent assay (ELISA) was used to measure serum antibody to capsid proteins in …

Background: Few human papillomavirus (HPV) seroprevalence studies have been carried
out in women from low-resource countries. Methods: Seroprevalence of antibodies against …

In a population-based study conducted in Guanacaste, Costa Rica, we investigated the
human papillomavirus (HPV) types detected in 233 cases of cervical intraepithelial …

To evaluate a possible association between infection with human papillomavirus (HPV) and
cervical cancer, we performed a multicenter case-control study in Latin America of 759 …

Objective: Summary of the studies carried out by the IARC on HPV and cervical cancer is
presented. Results: the first one was the international prevalence survey of HPV types in …

Serum samples from 194 cases and 217 controls participating in a case-control study of
invasive cervical cancer in Brazil were examined for antibodies to human papillomavirus …